doi:10.16150/j.1671-2870.2019.02.001

Abstract

CLC Number:

R715.2

References 28

[1]	Kaufmann SH, Parida SK. Tuberculosis in Africa: lear-ning from pathogenesis for biomarker identification[J]. Cell Host Microbe, 2008, 4(3):219-228.
[2]	World Health Organization (WHO). Global tuberculosis report, 2014[R/OL]. WHO, 2014[2018-12-29].https://www.who.int/tb/en/.
[3]	Minion J, Brunet L, Pai M. Fluorescent light emitting diode (LED) microscopy for the detection of Mycobacte-rium tuberculosis: a systematic review & meta-analysis[C/OL]. Geneva, Switzerland: WHO, 2009[2018-12-29].https://www.researchgate.net/publication/237765059_Fluores-cent_Light_Emitting_Diode_LED_Microscopy_for_the_Detection_of_Mycobacterium_tuberculosis_a_Systematic_Review_Meta-analysis
[4]	Dorman S. Advances in the diagnosis of tuberculosis: current status and future prospects[J]. Int J Tuberc Lung Dis, 2015, 19(5):504-516.
[5]	Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children[J]. Clin Infect Dis, 2017, 64(2):111-115.
[6]	Henry D. Isenberg. Clinical Microbiology Procedures Handbook[M]. 4th. America Society for Microbiology, 2007.
[7]	World Health Organization (WHO). Use of liquid TB culture and drug susceptibility testingDST in low and medium income settings: summary report of the expert group meeting on the use of liquid culture media[C]. WHO, 2007.
[8]	Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases[J]. Am J Respir Crit Care Med, 2007, 175(4):367-416.
[9]	World Health Organization(WHO). Implementing tuberculosis diagnostics: A policy framework[R/OL]. WHO, 2015[2018-12-29].https://www.who.int/tb/publications/implementing_TB_diagnostics/en/.
[10]	World Health Organization(WHO). Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB)[C]. WHO, 2008.
[11]	World Health Organization(WHO). Xpert MTB/RIF implementation manual Technical and operational ‘how-to’: practical considerations[R/OL]. WHO, 2014[2018-12-29].https://www.who.int/tb/publications/xpert_implem_manual/en/.
[12]	World Health Organization (WHO). The use of loop-media-ted isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance[R/OL]. WHO, 2016[2018-12-29].https://www.who.int/tb/publications/lamp-diagnosis-molecular/en/.
[13]	World Health Organization (WHO). Definitions and reporting framework for tuberculosis[C]. WHO, 2013.
[14]	WS288-2017肺结核诊断[S]. 中华人民共和国卫生行业标准, 2017.
[15]	World Health Organization( WHO). Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children[C]. WHO, 2013.
[16]	World Health Organization ( WHO). XpertMTB/RIF:WHO Policy Update and Implementation Manual[C]. WHO, 2014.
[17]	Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study[J]. Lancet Infect Dis, 2018, 18(1):76-84.
[18]	Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study[J]. Lancet Infect Dis, 2018, 18(1):68-75.
[19]	Lee YM, Kim SM, Park SJ, et al. Indeterminate T-SPOT.TB Test Results in Patients with Suspected Extrapulmonary Tuberculosis in Routine Clinical Practice[J]. Infect Chemother, 2013, 45(1):44-50.
[20]	Latorre I, Carrascosa JM, Vilavella M, et al. Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis[J]. J Infect, 2014, 69(6):600-606.
[21]	Lalvani A, Pareek M. Interferon gamma release assays: principles and practice[J]. Enferm Infecc Microbiol Clin, 2010, 28(4):245-252.
[22]	Ling DI, Pai M, Davids V, et al. Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?[J]. Eur Respir J, 2011, 38(3):649-656.
[23]	Wang F, Hou HY, Wu SJ, et al. Using the TBAg/PHA ratio in the T-SPOT(?).TB assay to distinguish TB disease from LTBI in an endemic area[J]. Int J Tuberc Lung Dis, 2016, 20(4):487-493.
[24]	Bosco MJ, Hou H, Mao L, et al. The performance of the TBAg/PHA ratio in the diagnosis of active TB disease in immunocompromised patients[J]. Int J Infect Dis, 2017, 59:55-60.
[25]	Zhou Y, Du J, Hou HY, et al. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy[J]. Front Cell Infect Microbiol, 2017, 7:457.
[26]	Wang F, Hou H, Zhou H, et al. Use of TBAg/PHA ratio in distinguishing tuberculoma from cancer in solitary pulmonary nodule or mass[J]. Clin Respir J, 2018, 12(3):1174-1181.
[27]	Wang F, Yu J, Zhou Y, et al. The Use of TB-Specific Antigen/Phytohemagglutinin Ratio for Diagnosis and Treatment Monitoring of Extrapulmonary Tuberculosis[J]. Front Immunol, 2018, 9:1047.
[28]	Wu X, Huang H, Hou H, et al. Diagnostic Performance of a 5-Marker Predictive Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease[J]. Inflamm Bowel Dis, 2018, 24(11):2452-2460.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 28

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 425-430.
[2]	. [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 419-424.
[3]	HUANG Chen, JING Feng, YANG Zhitao, et al . Exploration and practice of construction of nursing management system in shelter hospital [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 286-290.
[4]	LIANG Jing, HUANG Chen, JIANG Yan, et al . Management strategy of nursing for prevention and control of COVID-19 in emergency infusion room [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 281-285.
[5]	ZHANG Hong, ZHU Mengmeng, et al . Safety nursing for eating in the elderly during the COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 277-280.
[6]	ZHOU Jianping, YANG Zhenhua, WANG Yichen, et al . Practice and thinking of the medical team of the elderly medical assistance center in the prevention and control of COVID-19 in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 265-269.
[7]	ZHA Qinghua, WANG Xiaoning, ZHANG Yin, et al . Exploration and practice of nucleic acid sampling outside hospital during the epidemic period of COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 229-233.
[8]	YU Ping, QIU Weiyu, WANG Xu, et al . Practice and exploration of drug security management in large shelter hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 221-224.
[9]	JIANG Yan, LIN Wei, HUANG Chen, et al . Exploration and practice of emergency supplies management mode in emergency department under COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 212-215.
[10]	TANG Jie, MA Longxin, CAO Qing, et al . Study on the construction of smart shelter hospital based on new generation information technology [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 196-204.
[11]	JIANG Yan, CHEN Ting, HUANG Chen, PAN Peiqian, JING Feng, et al . Construction and practice of emergency response capability training program for all staff in emergency medical ward under COVID-19：Emergency response strategy [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 189-195.
[12]	MENG Jun, JIN Peipei, CHEN Changqiang, CHEN Jiuming, FAN Zhenjia, CHEN Shikai, DAI Jing, et al . Emergency transformation experience of the laboratory department of a hospital designated for admission of patients with novel coronavirus infection in emergency conversion [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 184-188.
[13]	SHI Yingying, ZHONG Xu, LIU Jialin, HE Le, XIONG Shaoji, WENG Y, DING Chengwei, YANG Y, CHEN Weihon, QIU Liping, XIN Haiguang. Hospital infection prevention and control practices in anti-epidemic medical staff and workers during COVID-19 epidemic: investigation and countermeasures [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 178-183.
[14]	DING Ning, CHEN Shikai, MENG Jun, DAI Jing, JIN Peipei, et al . Correlation and influencing factors analysis of the cycle threshold value in detection of novel coronavirus nucleic acid(Omicron) and the negative conversion cycle in infected patients [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 169-173.
[15]	YANG Zhitao, CHEN Ying, JING Feng, XIE Zhihui, ZHANG Yibo, SHANG Hanbin, LIN Jingsheng, WU Wenjuan, GU Zhidong, BI Yufang, CHEN Erzhen. Practice and Exploration on the construction of medical affairs management system in large Fangcang hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 154-159.